MAINZ BIOMED N.V.
Related Filers (3)
Financials (1)
NT 20-F
Monday, 5/2/2022
Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F for period ending 2021-12-31
Other (39)
6-K
Thursday, 11/16/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 11/15/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 11/13/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 9/13/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 8/15/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
D
Tuesday, 7/11/2023
Exempt (Private) Offering
6-K
Wednesday, 6/28/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 5/19/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/16/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Friday, 4/7/2023
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Tuesday, 2/21/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 1/20/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Friday, 1/6/2023
Notice of Effectiveness
CORRESP
Thursday, 1/5/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-3
Friday, 12/30/2022
Registration statement for specified transactions by certain foreign private issuers
6-K
Tuesday, 12/20/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 11/4/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 9/28/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 9/7/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 7/1/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 6/3/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Tuesday, 5/3/2022
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Friday, 1/28/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Tuesday, 1/25/2022
Notice of Effectiveness
CORRESP
Monday, 1/24/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Monday, 1/24/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-1
Friday, 1/21/2022
Registration statement for securities of certain foreign private issuers
6-K
Thursday, 1/6/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 11/12/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Thursday, 11/4/2021
Notice of Effectiveness
CERT
Wednesday, 11/3/2021
Certification by an exchange approving securities for listing
8-A12B
Wednesday, 11/3/2021
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
CORRESP
Tuesday, 11/2/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 11/2/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-1/A
Tuesday, 11/2/2021
Registration statement for securities of certain foreign private issuers
F-1/A
Tuesday, 10/26/2021
Registration statement for securities of certain foreign private issuers
F-1
Tuesday, 10/12/2021
Registration statement for securities of certain foreign private issuers
CORRESP
Friday, 10/8/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
D
Wednesday, 9/8/2021
Exempt (Private) Offering
Ownership (4)
SC 13G/A
Tuesday, 2/13/2024
KfW: Major Shareholders
SC 13G
Wednesday, 3/1/2023
KfW: Major Shareholders
SC 13G
Monday, 5/16/2022
Hekland Hans: Major Shareholders
SC 13G
Monday, 5/16/2022
Eidens Moritz: Major Shareholders
Prospectus (13)
424B5
Tuesday, 11/14/2023
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Tuesday, 9/26/2023
Prospectus filed pursuant to Rule 424(b)(5)
S-8
Tuesday, 7/11/2023
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B5
Wednesday, 6/28/2023
Prospectus filed pursuant to Rule 424(b)(5)
424B3
Tuesday, 1/10/2023
Prospectus filed pursuant to Rule 424(b)(3)
424B3
Friday, 1/28/2022
Prospectus filed pursuant to Rule 424(b)(3)
DRS
Friday, 1/14/2022
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
424B3
Friday, 11/12/2021
Prospectus filed pursuant to Rule 424(b)(3)
424B3
Friday, 11/12/2021
Prospectus filed pursuant to Rule 424(b)(3)
FWP
Tuesday, 10/26/2021
Filing under Securities Act Rules 163/433 of free writing prospectuses
DRSLTR
Friday, 9/3/2021
Correspondence Related to Draft Registration Statement
DRS/A
Friday, 9/3/2021
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRS
Tuesday, 8/3/2021
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy